Name: Innoviva (INVA) shares outstanding since 2005, split adjusted
Creator: Buyback Radar
License: https://creativecommons.org/licenses/by/4.0/

Shares outstanding, 2005 to todaysplit adjusted, from SEC filings

2005, 43,710,1412026-07-31, 72,245,485

Early years use the fiscal-year average share count from the 10-K.

A share bought in 2011

1.2× more of Innoviva today, without buying another share. It was one of 86,149,162 shares then. It is one of 72,245,485 now.

Every filing we read21 fiscal years, split adjusted

Fiscal year	Date	Shares outstanding	Filing
2005	2005-02-28	43,710,141	10-K	cover page
2006	2006-02-15	49,858,332	10-K/A	cover page
2007	2007-02-15	50,794,120	10-K	cover page
2008	2008-02-15	51,696,607	10-K	cover page
2009	2009-12-31	63,027,000	10-K	fiscal-year average
2010	2010-12-31	72,070,000	10-K	fiscal-year average
2011	2012-02-17	86,149,162	10-K
2012	2013-02-14	98,451,008	10-K
2013	2014-02-14	111,976,127	10-K
2014	2015-02-12	116,624,973	10-K
2015	2016-02-16	114,117,517	10-K
2016	2017-02-24	109,201,168	10-K
2017	2018-02-16	101,824,355	10-K
2018	2019-02-11	101,123,024	10-K
2019	2020-02-11	101,300,967	10-K/A
2020	2021-02-12	101,392,397	10-K
2021	2022-02-14	69,565,501	10-K/A
2022	2023-02-14	68,126,089	10-K/A
2023	2024-02-14	63,227,333	10-K/A
2024	2025-02-14	62,675,545	10-K/A
2025	2026-02-13	74,073,646	10-K/A

Source: all 10-K filings of Innoviva on EDGAR. Download this series as CSV. Licence CC BY 4.0, credit Buyback Radar.

What the buybacks cost, since fiscal 2015cash flow statement against share count

$699Mspent on buybacks

44Mfewer shares outstanding

$16spent per share that actually disappeared

$63Mpaid in stock compensation over the same years

Part of every buyback only replaces shares handed to employees. That part costs money and retires nothing, so the cost per share that disappeared is higher than the average price the company paid.

The stock, long termprice chart by TradingView

Loads a chart from TradingView, which may set its own cookies.

Insider buying, last 12 months

No open-market purchases reported in the last 12 months.

The story

The numbers say what happened. The story says whether it can continue. We cover companies like Innoviva in depth on Cannibal Stocks.

Read Cannibal Stocks